Yissum Technology Transfer Company of the Hebrew University

Name: Yissum Technology Transfer Company of the Hebrew University
Address: Givat-Ram, Jerusalem, 91390, IL
Telephone: +97226586688

Home
Israel
Jerusalem
Yissum Technology Transfer Company of the Hebrew University

Yissum is the technology transfer company of the Hebrew University of Jerusalem (HU). It is responsib

Yissum is the Technology Transfer company of The Hebrew University of Jerusalem. Our mission is to benefit society by converting extraordinary innovations and transformational technologies into commercial solutions that address our most urgent global challenges. We are leaders in innovation and experts in technology and evaluation acquisition strategies. Together with Hebrew University’s top resea

rchers, Yissum is bridging breakthrough academic research with scientific and commercial applications.

16/06/2026

HUJI PharmaLeap invites you to explore the future of drug development.

AI, machine learning, big data, and emerging digital technologies are no longer distant possibilities for the pharmaceutical industry, they are already reshaping how new therapies are discovered, developed, and brought closer to patients.

Join us for the next session in the HUJI PharmaLeap Seminar Series, created to bridge applied academic research in pharma with industry development, implementation, and real-world therapeutic impact.

Our upcoming lecture will feature Eran Harary, MD, Senior Vice President in the global innovative medicines R&D organization at Teva Pharmaceuticals, who will share insights on:

🔹 How AI and new technologies are transforming pharmaceutical R&D
🔹 The future of drug development toward 2030
🔹 Building R&D capabilities in AI, machine learning, and big data
🔹 Advancing academic discoveries toward clinical and industrial impact

📅 Upcoming session:
“Pharma 2030: How AI and New Technologies Are Reshaping Drug Development”

🎙 Speaker:
Eran Harary, MD
Senior Vice President, Global Innovative Medicines R&D, Teva Pharmaceuticals

🗓 June 17, 2026
🕦 11:45 | Gathering & Refreshments
🕛 12:00 | Lecture
📍 Rubin Hall, Ein Kerem Campus

The series is led by The Hebrew University of Jerusalem Academia-Industry Relations, Yissum | The Hebrew University Tech Transfer Company, and the Faculty of Medicine, bringing together researchers, graduate students, clinicians, entrepreneurs, and industry leaders to strengthen the bridge between academic discovery and therapeutic impact.

🔗 Registration: https://tinyurl.com/yc2w3mvm

Join us for a forward-looking discussion on the technologies shaping the next era of pharma innovation.

The Hebrew University of Jerusalem בית הספר לרוקחות, האוניברסיטה העברית בירושלים School Of Pharmacy, HUJI הפקולטה לרפואה האוניברסיטה העברית Faculty of Medicine ביולוגיה בעברית Teva Pharmaceutical Industries Ltd.

11/06/2026

🌍 One of the world's leading global health organizations has just validated technology born at The Hebrew University of Jerusalem.

🚀 Salignostics has received a $1.87 million grant from the Bill & Melinda Gates Foundation to develop saliva-based rapid tests for HIV and pregnancy in low and middle income countries.

❓ Why is this important? Because for millions of people worldwide, access to diagnostic testing remains a challenge.

🩸 Many tests still require blood draws, trained personnel, and laboratory infrastructure. In many settings, those barriers can delay or prevent early detection altogether.

💡 Salignostics is taking a different approach.

Built on research from The Hebrew University, the company is developing saliva based diagnostics that are:
👉 Non-invasive
⚡ Rapid and lab-grade
🌍 Affordable and accessible

In other words:
🩸 blood → 👄 saliva
🏥 labs → 📍 point-of-care testing
🔬 complex procedures → 🤝 accessible diagnostics

🎓 What began with four PhD students at The Hebrew University working under Prof. Aaron Palmon, who today serves as the Vice President for Research & Development at the Hebrew University, has grown into a company with global impact.

⭐ This Gates Foundation grant is more than funding. It's a powerful validation of a technology that could help bring critical testing closer to the people who need it most.

📈 It is also a testament to the impact that can be achieved when breakthrough academic research is translated into real-world solutions.

👏 Congratulations to Prof. Aaron Palmon, Dr. Guy Krief, Dr. Omer Deutsch, Yoav Neuman, Dr. Raluca Cohen and the entire Salignostics team on this outstanding achievement. We are proud to support your journey and excited to see the impact ahead.

🔗 Full Calcalistech article:
https://tinyurl.com/yu347494

Photo Credit: Osnat Krasnansky

Salignostics Ltd
The Hebrew University of Jerusalem
Gates Foundation

04/06/2026

🚨 A world-first gene therapy treatment didn't start in an operating room.

It started with a scientific question in an academic laboratory.

An infant with a devastating rare genetic epilepsy has become the first person ever to receive a missing gene delivered directly into the brain. Just one month after the procedure, the child's severe seizures had stopped.

What makes this breakthrough remarkable is not only the outcome, but the speed and collaboration that made it possible.

The foundation was laid by Prof. Rami Aqeilan at The Hebrew University of Jerusalem, whose research uncovered the role of the WWOX gene and demonstrated its therapeutic potential in disease models and patient-derived brain organoids.

Yissum | The Hebrew University Tech Transfer Company, helped move the discovery beyond academia by licensing the technology to Mahzi Therapeutics, led by CEO Dr. Yael Weiss, which developed the clinical-grade gene therapy.

The final step required exceptional clinical leadership from Dr. Naama Orenstein and Dr. Ido Ben Zvi, MD at Schneider Children's Medical Center of Israel, together with close collaboration from the Israeli Ministry of Health to enable this first-in-human treatment.

One child. One breakthrough. Potentially a new path for treating rare neurodevelopmental genetic diseases.

A huge congratulations from Yissum to everyone who made this historic milestone possible - from the pioneering research team, to the innovators who translated the science into a therapeutic solution, to the clinicians who courageously delivered this first-in-human treatment, and to the regulatory partners who helped make it possible.

This achievement is a powerful reminder of what can happen when academia, industry, healthcare, and government work together to turn scientific discoveries into life-changing therapies.

Read the full story:
https://tinyurl.com/4zr9mvss

(Photo: Schneider Spokesperson)

The Hebrew University of Jerusalem מרכז שניידר לרפואת ילדים בישראל משרד הבריאות

28/05/2026

🚀 A Historic Milestone for Jerusalem’s Innovation Ecosystem 🏙️

This week, Jerusalem officially launched a groundbreaking new chapter in Israeli innovation, healthcare, research, and entrepreneurship 🔬💡🏥. At a festive event held at the Gav-Yam complex on the Edmond J. Safra Campus of The Hebrew University of Jerusalem in Givat Ram 🎓, the city launched the first joint academic body of its kind in Israel, established as part of the Jerusalem Innovation District 🌍.

The initiative is a strategic collaboration between:
🏛️ The Hebrew University of Jerusalem
🏥 Shaare Zedek Medical Center, Jerusalem
⚙️ Azrieli College of Engineering Jerusalem (עזריאלי מכללה אקדמית להנדסה ירושלים)
📚 Jerusalem College of Technology (JCT) - Lev Academic Center
Together with: Jerusalem Municipality & The Jerusalem Development Authority (JDA) 🏙️📈

This unprecedented platform bridges academia, healthcare, industry, and entrepreneurship 🤝 to promote applied research, tech commercialization, startup creation, human capital, and ecosystem connections 🌐.

The event was attended by:
👤 Moshe Leon, Mayor of Jerusalem; Prof. Oron Shagrir, Rector of the Hebrew University; Dr. Alon Stopel, Chairman of the Innovation Authority; Tzachi Namir, CEO of JDA; and leading figures from Israel’s ecosystem.

💬 Official Greetings:

📜 President Isaac Herzog: “The Jerusalem Innovation District is a promise that will propel Jerusalem forward. Its strength lies in the unique synergy created between the city’s institutions—science, engineering, medicine, entrepreneurship, and culture sharing one space.”

🏙️ Mayor Moshe Leon: “Jerusalem continues to strengthen its position as a global leader in innovation. The District creates a unique ecosystem where ideas become real solutions with international impact.”

🎓 Prof. Tamir Sheafer, President of The Hebrew University of Jerusalem: “This collaboration will create synergy between Jerusalem’s academic institutions. It will strengthen the scientific ecosystem and position the District as a central engine for growth.”

Pics: Dana Bar Siman Tov
Production: NITZOZOT PRODUCTIONS

המרכז הרפואי שערי צדק עזריאלי מכללה אקדמית להנדסה ירושלים המרכז האקדמי לב
עיריית ירושלים iTravelJerusalem Dana Bar Siman Tov ניצוצות הפקת אירועים

26/05/2026

💡 Great science doesn’t fail because of bad ideas.

It fails because crossing the “Valley of Death” between academia and industry is incredibly hard.

This week, we launched the HUJI PharmaLeap Seminar Series with our inaugural webinar, “Early Design for Crossing the Valley of Death,” featuring Gilead Raday, Founder & CEO of RAD Therapeutics.

Gilead shared valuable insights on how early translational design can reduce risk and strengthen the path from promising academic discoveries to industry-ready therapeutic opportunities.

The HUJI PharmaLeap Seminar Series, initiated by the Academia-Industry Relations Authority, Yissum | The Hebrew University Tech Transfer Company, and the Faculty of Medicine, was created to bridge applied academic pharma research with real-world drug development.

Through upcoming webinars and expert-led sessions, the series will provide researchers and graduate students with practical tools, industry perspectives, and clearer pathways for translating outstanding science into clinical and industrial impact.

Excited for what’s ahead.

💡Yissum.
Your Innovation. Our Journey. Shared Impact.

The Hebrew University of Jerusalem

20/05/2026

🧬 Why Does Life Prefer One Molecular “Hand” Over the Other? A New Quantum Discovery May Hold the Answer 🧬

A groundbreaking study led by Prof. Yossi Paltiel of The Hebrew University of Jerusalem and Prof. Ron Naaman of the Weizmann Institute of Science offers a striking new explanation for one of science’s oldest mysteries: why life consistently selects one mirror-image form of molecules over the other.

Published in Science Advances, the research reveals that electron spin, a fundamental quantum property, may dynamically break molecular symmetry and influence how chiral molecules behave.

Many essential biological molecules exist in two mirror-image forms, known as enantiomers. Chemically, these forms are nearly identical, yet biology overwhelmingly favors only one version:
• Amino acids are almost exclusively “left-handed”
• Sugars are predominantly “right-handed”

For decades, scientists struggled to understand how this universal preference emerged.

🔬 The new study demonstrates that during dynamic electronic processes, electron spin interacts differently with opposite molecular enantiomers, creating measurable asymmetries between molecules previously thought to behave identically.

This work builds on the pioneering field of Chiral Induced Spin Selectivity (CISS), a phenomenon that has become one of the most exciting intersections of quantum physics, chemistry, biology, and materials science.

🚀 Why this matters
Beyond addressing a fundamental question about the origin of biological homochirality, the findings may open new directions for:
• Spintronics and quantum materials
• Molecular electronics
• Enantioselective chemistry
• Advanced sensing technologies
• Bio-inspired quantum systems

The study highlights how quantum-level spin effects may play a far more central role in biological and chemical systems than previously understood.

👏 Congratulations to Prof. Yossi Paltiel, Prof. Ron Naaman, and collaborators on this remarkable scientific achievement.

🤝 Yissum | The Hebrew University Tech Transfer Company invites companies, investors, and innovation partners in quantum technologies, advanced materials, chemistry, and life sciences to connect with us and explore emerging opportunities from frontier research at The Hebrew University.

🤝 Yissum.
Your Innovation. Our Journey. Shared Impact.

Read more: https://tinyurl.com/3x5s2uv5

17/05/2026

🚀 Innovation Corner #7: Wrapping up the first season of Innovation Corner with KLA Israel President Ori Tadmor

What does it really take to power the AI revolution?

Behind every breakthrough in Generative AI stands an invisible world of semiconductors, advanced chip architectures, precision manufacturing, and engineering at extraordinary scale. Humanity keeps asking AI to do bigger things, while the semiconductor industry quietly performs technological sorcery in the background to keep it all running.

Researchers and students at The Hebrew University of Jerusalem are invited to join:

Behind the AI Revolution: From Silicon to Intelligence

🎤 Ori Tadmor
VP Operations, KLA
President, KLA Israel

📅 Wednesday, June 10, 2026
🕐 13:00
📍 Engineering Auditorium, Building A, Room 300
School of Engineering and Computer Science
Edmond J. Safra Campus

In this special closing meetup of the first Innovation Corner season, Ori will explore:
⚡ How AI is reshaping the semiconductor industry
⚡ The rise of specialized AI chip architectures
⚡ Advanced packaging technologies driving next-generation systems
⚡ The growing importance of process control, metrology, and analytics
⚡ The engineering challenges behind scalable and reliable AI infrastructure

With more than 30 years at KLA, Ori brings firsthand experience from the frontlines of one of the world’s most advanced and demanding industries. Since joining KLA in 1994 as a development engineer and becoming one of the first employees of KLA Israel, he has led multidisciplinary teams across hardware, optics, algorithms, software, engineering, and operations while working closely with leading semiconductor manufacturers worldwide.

Hosted by Yissum | The Hebrew University Tech Transfer Company, the Hebrew University’s Industry-Academia Relations Authority, and the Edmond and Lily Safra Center for Brain Sciences - ELSC.

Looking forward to closing the season with one of the leaders helping shape the technological foundation of the AI era.

Seats are limited. Advance registration required.

Register Now:
https://tinyurl.com/ezpxfam6

KLA Corporation The Hebrew University of Jerusalem

14/05/2026

🚀 HUJI PharmaLeap invites you to get the tools to turn academic discoveries into real-world therapies.

Too many breakthrough ideas never make it beyond the lab. Between promising research and patient impact lies the biotech “Valley of Death” where science, funding, regulation, and commercialization collide.

To help bridge that gap, the The Hebrew University of Jerusalem Academia-Industry Relations, Yissum | The Hebrew University Tech Transfer Company, and the Faculty of Medicine are launching HUJI PharmaLeap - a new seminar series connecting researchers, clinicians, entrepreneurs, and industry leaders.

Through monthly webinars and expert-led discussions, participants will gain practical insights into:
🔹 Drug development
🔹 Translational and industry-oriented research
🔹 Regulation & commercialization
🔹 Working with investors and pharma partners
🔹 Advancing innovation from academia to clinical impact

📅 Opening session (online):
“Early Design for Crossing the Valley of Death”
🎙️ Gilead Raday, Founder & CEO, RAD Therapeutics Inc.
🗓️ May 19, 2026 | 16:00 | 💻 Zoom Webinar

🔗 Registration:
https://tinyurl.com/whr3df47

Join us in building a stronger bridge between groundbreaking research and industrial innovation.

The Hebrew University of Jerusalem

11/05/2026

🧠🤝 Harvard University and The Hebrew University of Jerusalem are joining forces to advance NeuroAI.

The new collaboration between the Kempner Institute at Harvard University and the Edmond and Lily Safra Center for Brain Sciences - ELSC at The Hebrew University of Jerusalem, will bring together leading researchers in neuroscience, machine learning, cognitive science, and artificial intelligence to explore one of science’s biggest questions: how intelligence works across biological and artificial systems. 🌍🔬💡

Through joint workshops, faculty engagement, and trainee exchange, the initiative will advance interdisciplinary research at the intersection of brain science and AI and explore how insights from the brain can inspire more robust and efficient AI systems. 🧠⚡🤖

The collaboration builds on strong existing scientific ties between the two communities, including collaborations involving Prof. Haim Sompolinsky, Prof. Daphna Weinshall, and Dr. Jonathan Kadmon. 👨‍🔬👩‍🔬👨‍🔬

🚀🌐 At Yissum, we congratulate the Kempner Institute at Harvard University and the Edmond and Lily Safra Center for Brain Sciences - ELSC at The Hebrew University of Jerusalem on this exciting new NeuroAI collaboration, and look forward to supporting the groundbreaking research emerging from this partnership by helping connect transformative science with global innovation opportunities.

Harvard University
ELSC
The Hebrew University of Jerusalem
Haim Sompolinsky

07/05/2026

🚀 Breakthrough research. 🎓 Inspiring teaching. 🌍 Global recognition.

Yissum | The Hebrew University Tech Transfer Company proudly congratulates Dr. Or Ordentlich on receiving the 2026 James L. Massey Research & Teaching Award for Young Scholars. One of the most prestigious honors in the Information Theory community.

🔬 Dr. Ordentlich’s work bridges deep theoretical insight and real-world impact, spanning pure mathematics, core information theory, and cutting-edge AI systems. His contributions, including advances in lattice geometry and efficient inference for large language models, continue to shape the future of data science and communication.

👩‍🏫 Just as impressive is his impact in the classroom. At The Hebrew University of Jerusalem, he has transformed information theory into a cornerstone of the curriculum, mentoring a new generation of researchers who are already making their mark worldwide.

👏 We are proud to celebrate this outstanding achievement and the continued excellence it represents.

Congratulations, Or, on this well-deserved recognition.

Read More: https://tinyurl.com/2wdrccbp

Or Ordentlich
IEEE
The Hebrew University of Jerusalem

Address

Givat-Ram
Jerusalem
91390

Telephone

+97226586688

Website

http://www.yissum.co.il/

Alerts

Be the first to know and let us send you an email when Yissum Technology Transfer Company of the Hebrew University posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Yissum Technology Transfer Company of the Hebrew University:

Shortcuts

Want your business to be the top-listed Engineering Company in Jerusalem?